Hims & Hers Health shares technical analysis: Resistance test at $33.79 after strong earnings

Traders Union
All News
Stocks
Hims & Hers Health jumps 6.13% today

Highlights

Hims & Hers Health reported $753.2 million in revenue, a 38.2% increase compared to the prior year.
Management raised guidance and reported 307,000 new customers, bringing the total to 2.89 million.
Shares of Hims & Hers Health recently climbed 6.13% amid bullish technical structure, with a forecasted $29.53 to $33.79 trading range.

Investor demand rises as revenue growth and guidance boost outlook

Hims & Hers Health has reported revenues of $753.2 million, representing a 38.2% increase compared to the prior year and pointing to strong sales momentum. This robust top-line performance drives renewed investor demand by confirming effective business execution and higher market value. Management's decision to raise guidance further highlights expectations of continued strength, while the addition of 307,000 new customers to a total of 2.89 million underscores sustained user growth and future recurring revenue potential.

Technical support holds as oscillators warn of overbought risk

HIMS is showing firm technical support, with price levels sustained above the MA-20 at $30.99 and MA-50 at $31.33 on the hourly chart, as well as above the MA-200 at $28.67 on the daily timeframe. The Ichimoku Kijun sits at $31.06, acting as immediate support. Among oscillators, RSI stands at 57.18, suggesting a slight bullish bias, while MACD and ADX remain neutral. Stoch RSI and Bull/Bear Power both flag overbought conditions, and CCI is consistent with the potential for additional gains. Awesome Oscillator provides a neutral read, indicating the absence of strong directional momentum. Intraday action reflected high volatility and aggressive buyer presence, but the mixed signals from oscillators signal caution for possible short-term pullbacks.

Volatile range likely as upside probability outweighs reversal risk

In the short term, HIMS is likely to trade within a volatile range of $29.53 to $33.79. There is a 70% probability of continued upside, while a reversal remains less likely at 30%. If the current trend persists, price could consolidate within this band. A push above resistance would prompt a test of the upper bound, while any breakdown below support could see prices retest lower levels inside the projected volatility range.

Anton Kharitonov, expert at Traders Union, sees underlying strength in Hims & Hers Health following robust revenue growth and customer gains. He remains cautious due to overbought signals and intraday volatility, as technical indicators show mixed momentum. The base case is for range trading between $29.53 and $33.79, with upside only sustainable if support levels hold. "Until we see clear confirmation above major resistance, I would stay defensive and wait for a better risk-reward entry."

Previously it was reported that strong financial guidance and new partnerships had sparked improved sentiment and fresh buying interest in Hims & Hers Health. The current technical set-up, supported by both accelerating revenue growth and robust price action, strengthens the case for continued upside, with traders now advised to watch for a breakout or pullback as volatility persists within the $29.53 to $33.79 trading range.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.